ADT Increases Our Risk for Developing Alzheimer’s and Not By A Little!
New information about a possible bad side effect of hormone therapy (ADT) for men with prostate cancer was just published and it is frightening for men on hormone therapy (ADT). The findings are a result [...]
Data Supports A Radical Prostatectomy Option for Some Localized Advanced Prostate Cancer
I have often had men recently diagnosed with advanced, metastatic prostate cancer call me and ask if surgery makes any sense for them to consider. I have never been sure how to respond given that [...]
About the Important Genetic Prostate Cancer Study (UKGPCS) in the United Kingdom
Cancer is a genetic disease, so prostate cancer is a genetic problem. This statement might be the most important one we can make when trying to describe the current, overall situation we face as prostate [...]
Understanding What is Neuroendocrine Differentiation in Prostate Cancer
Understanding a little about the prostate gland and its biology is not only interesting, but it allows us to ask some important questions that can positively inform our treatment decisions and eventually the outcomes. On [...]
Initial Gleason Score Does Not Impact Abiraterone (Zytiga) Benefit in Prostate Cancer
Clinical trials have shown that there is an overall survival and radiographic progression-free survival benefit derived from abiraterone acetate (Zytiga) in the treatment of men with metastatic castration resistant prostate cancer (mCRPC). A new retrospective [...]
What Are The Negative Prognostic Factors You Should Know When You Have A Biochemical Prostate Cancer Occurrence
Knowing the negative prognostic factors for successful treatment when you have a a biochemical recurrence (PSA only) of your prostate cancer is important. These factors can help you make your treatment decisions because they assist [...]